Hunter P. Curry, PharmD
@huntercurry23.bsky.social
PGY-2 Infectious Diseases Resident at University of Kentucky
Interested in pediatrics, gram negative resistance, and PK/PD
#MedSky #PharmSky #IDSky #PedsID
Interested in pediatrics, gram negative resistance, and PK/PD
#MedSky #PharmSky #IDSky #PedsID
Reposted by Hunter P. Curry, PharmD
Check out the incredible work of our members at #ESCMIDGlobal 2025 including Dr. Nicole Slain as she shares insight on how cefepime compares to carbapenem therapy for deep-seated Amp-C producing infections! 🦠 @ashlan-kunz-coyne.bsky.social
April 14, 2025 at 10:01 AM
Check out the incredible work of our members at #ESCMIDGlobal 2025 including Dr. Nicole Slain as she shares insight on how cefepime compares to carbapenem therapy for deep-seated Amp-C producing infections! 🦠 @ashlan-kunz-coyne.bsky.social
Presenting my research in Austria wasn’t on the bingo card for PGY-2 year, but with great mentorship here I am!
We found no difference in primary endpoint of 30-day clinical failure for patients receiving combo (n=91) vs mono (n=99) therapy for monomicrobial, deep-seated S maltophilia infections
We found no difference in primary endpoint of 30-day clinical failure for patients receiving combo (n=91) vs mono (n=99) therapy for monomicrobial, deep-seated S maltophilia infections
Be sure not to miss this one from Dr. @huntercurry23.bsky.social & team at #ESCMIDGlobal 2025 as he shares their findings for deep-seated S. maltophilia infections, which identified protective effects against clinical failure when using LVX/SXT or LVX/MIN.💊 @ashlan-kunz-coyne.bsky.social
April 14, 2025 at 12:17 PM
Presenting my research in Austria wasn’t on the bingo card for PGY-2 year, but with great mentorship here I am!
We found no difference in primary endpoint of 30-day clinical failure for patients receiving combo (n=91) vs mono (n=99) therapy for monomicrobial, deep-seated S maltophilia infections
We found no difference in primary endpoint of 30-day clinical failure for patients receiving combo (n=91) vs mono (n=99) therapy for monomicrobial, deep-seated S maltophilia infections
Enjoyed working on this journal club! Free 1.5 hr BCIDP/ACPE credit for SIDP members. Full journal club series: www.sidp.org/SIDPEC
March 15, 2025 at 8:24 PM
Enjoyed working on this journal club! Free 1.5 hr BCIDP/ACPE credit for SIDP members. Full journal club series: www.sidp.org/SIDPEC
Reposted by Hunter P. Curry, PharmD
🚨 October 2024 Critical Care Clinical Pearl 🏥
NMBA in ARDS 🫁
Ft: Maggie Schmidt
🎥 https://buff.ly/4irgEFo
NMBA in ARDS 🫁
Ft: Maggie Schmidt
🎥 https://buff.ly/4irgEFo
December 6, 2024 at 6:58 PM
🚨 October 2024 Critical Care Clinical Pearl 🏥
NMBA in ARDS 🫁
Ft: Maggie Schmidt
🎥 https://buff.ly/4irgEFo
NMBA in ARDS 🫁
Ft: Maggie Schmidt
🎥 https://buff.ly/4irgEFo
Reposted by Hunter P. Curry, PharmD
2024 is coming to a close! Check out our SIDP Wrapped! 🎊 #stewardship #infectiousdiseases
December 5, 2024 at 11:00 PM
2024 is coming to a close! Check out our SIDP Wrapped! 🎊 #stewardship #infectiousdiseases
Reposted by Hunter P. Curry, PharmD
it’s the happiest Thursday because @sidpharm.bsky.social and the @escmid.bsky.social PK PD study group are bringing back ICAAC (in spirit)!!!!
Registration will open next week! The Midwest in the summer is magical - come join us!
sidp.org/page-1543694
#idsky #amssky #pharmsky
Registration will open next week! The Midwest in the summer is magical - come join us!
sidp.org/page-1543694
#idsky #amssky #pharmsky
December 5, 2024 at 12:52 PM
it’s the happiest Thursday because @sidpharm.bsky.social and the @escmid.bsky.social PK PD study group are bringing back ICAAC (in spirit)!!!!
Registration will open next week! The Midwest in the summer is magical - come join us!
sidp.org/page-1543694
#idsky #amssky #pharmsky
Registration will open next week! The Midwest in the summer is magical - come join us!
sidp.org/page-1543694
#idsky #amssky #pharmsky
Join the ID Pharmacy team at the University of Kentucky! Share with residents looking for an ID PGY-2 spot.
UK HealthCare is recruiting for 2 of 3 PGY-2 infectious diseases spots for the ‘24-25 cycle.
1 traditional ID (in addition to 1 resident that early committed)
and
1 pediatric ID focus
UK HealthCare is recruiting for 2 of 3 PGY-2 infectious diseases spots for the ‘24-25 cycle.
1 traditional ID (in addition to 1 resident that early committed)
and
1 pediatric ID focus
December 5, 2024 at 1:03 AM
Join the ID Pharmacy team at the University of Kentucky! Share with residents looking for an ID PGY-2 spot.
UK HealthCare is recruiting for 2 of 3 PGY-2 infectious diseases spots for the ‘24-25 cycle.
1 traditional ID (in addition to 1 resident that early committed)
and
1 pediatric ID focus
UK HealthCare is recruiting for 2 of 3 PGY-2 infectious diseases spots for the ‘24-25 cycle.
1 traditional ID (in addition to 1 resident that early committed)
and
1 pediatric ID focus
🆕️⚡️⚡️Retrospective, multicenter, cohort study
Oral antibiotics Vs OPAT
Discharge oral therapy was not associated with higher rates of treatment failure compared to OPAT for children with MRSA bacteremic osteomyelitis #idsky
link.springer.com/article/10.1...
Oral antibiotics Vs OPAT
Discharge oral therapy was not associated with higher rates of treatment failure compared to OPAT for children with MRSA bacteremic osteomyelitis #idsky
link.springer.com/article/10.1...
Association of Antibiotic Route and Outcomes in Children with Methicillin-Resistant Staphylococcus aureus Bacteremic Osteomyelitis - Infectious Diseases and Therapy
Introduction There remains uncertainty about whether transitioning to oral antibiotic therapy is appropriate for the management of children with methicillin-resistant Staphylococcus aureus (MRSA) bact...
link.springer.com
November 18, 2024 at 10:16 PM
Learning about SEV (simulated endocardial vegetation) models! ID pharmacy residents at UK can spend a month in the PK/PD lab at the college and learn how to do bench top studies.
Step 1: make the clot, then inoculate it with organism (working with Enterobacter cloacae with KPC-3)
#IDSky #MedSky
Step 1: make the clot, then inoculate it with organism (working with Enterobacter cloacae with KPC-3)
#IDSky #MedSky
November 18, 2024 at 10:16 PM
Reposted by Hunter P. Curry, PharmD
🔥In Case You Missed It🔥
Our NEW WikiGuidelines
A stellar cast of auth🌟rs
54 members , 12 countries
The Third WikiGuidelines
After OM,IE
Guidelines for the Prevention Diagnosis,and Management of Urinary Tract Infections in Pediatrics & Adults #idsky
#JAMANetworkOpen
jamanetwork.com/journals/jam...
Our NEW WikiGuidelines
A stellar cast of auth🌟rs
54 members , 12 countries
The Third WikiGuidelines
After OM,IE
Guidelines for the Prevention Diagnosis,and Management of Urinary Tract Infections in Pediatrics & Adults #idsky
#JAMANetworkOpen
jamanetwork.com/journals/jam...
November 15, 2024 at 11:51 PM
🔥In Case You Missed It🔥
Our NEW WikiGuidelines
A stellar cast of auth🌟rs
54 members , 12 countries
The Third WikiGuidelines
After OM,IE
Guidelines for the Prevention Diagnosis,and Management of Urinary Tract Infections in Pediatrics & Adults #idsky
#JAMANetworkOpen
jamanetwork.com/journals/jam...
Our NEW WikiGuidelines
A stellar cast of auth🌟rs
54 members , 12 countries
The Third WikiGuidelines
After OM,IE
Guidelines for the Prevention Diagnosis,and Management of Urinary Tract Infections in Pediatrics & Adults #idsky
#JAMANetworkOpen
jamanetwork.com/journals/jam...
Reposted by Hunter P. Curry, PharmD
🆕️⚡️⚡️Case series and review of literature #JAC
Use of echinocandins + clindamycin in Pneumocystis pneumonia
Echinocandin & clindamycin may be a safe & effective alternative treatment for patients who can't be given co-trimoxazole for PCP #idsky
academic.oup.com/jac/advance-...
Use of echinocandins + clindamycin in Pneumocystis pneumonia
Echinocandin & clindamycin may be a safe & effective alternative treatment for patients who can't be given co-trimoxazole for PCP #idsky
academic.oup.com/jac/advance-...
Use of echinocandins combined with clindamycin in Pneumocystis pneumonia: a case series of 14 patients
AbstractBackground. Pneumocystis jirovecii pneumonia (PcP) is an opportunistic infection for which the standard of care is co-trimoxazole. However, safety
academic.oup.com
November 13, 2024 at 6:33 PM
🆕️⚡️⚡️Case series and review of literature #JAC
Use of echinocandins + clindamycin in Pneumocystis pneumonia
Echinocandin & clindamycin may be a safe & effective alternative treatment for patients who can't be given co-trimoxazole for PCP #idsky
academic.oup.com/jac/advance-...
Use of echinocandins + clindamycin in Pneumocystis pneumonia
Echinocandin & clindamycin may be a safe & effective alternative treatment for patients who can't be given co-trimoxazole for PCP #idsky
academic.oup.com/jac/advance-...
Reposted by Hunter P. Curry, PharmD
The pediatric ID starter pack is here!
Please suggest additions and also follow the PedsIDSky feed. #PedsIDSky #PedsID
And also follow the amazing communities at #IDSky #EpiSky #PedSky!
go.bsky.app/5M119ru
Please suggest additions and also follow the PedsIDSky feed. #PedsIDSky #PedsID
And also follow the amazing communities at #IDSky #EpiSky #PedSky!
go.bsky.app/5M119ru
November 10, 2024 at 8:30 PM
The pediatric ID starter pack is here!
Please suggest additions and also follow the PedsIDSky feed. #PedsIDSky #PedsID
And also follow the amazing communities at #IDSky #EpiSky #PedSky!
go.bsky.app/5M119ru
Please suggest additions and also follow the PedsIDSky feed. #PedsIDSky #PedsID
And also follow the amazing communities at #IDSky #EpiSky #PedSky!
go.bsky.app/5M119ru